79. Direct-to-Inject Buprenorphine

In episode 79 we discuss an article about starting long-acting injectable buprenorphine without a sublingual test dose. 

Rosenwohl-Mack S, Heeney M, Samuel L, Anderson E, Herring AA, Sirey LR, Peterson D, Bazazi AR, Snyder H, Suen LW. “Outpatient initiation of direct-to-inject buprenorphine.” Drug and alcohol dependence vol. 278 (2026): 113011. doi:10.1016/j.drugalcdep.2025.113011

We also discuss keeping up with addiction medicine news from the current administration, and an articlre commendation from one of our listeners. 

 

KFF: The independent source for health policy research, polling, and news. 

KFF: View the Latest: Substance Use 

KFF: Tracking Key Mental Health and Substance Use Policy Actions Under the Trump Administration 

CBS News: New White House drug abuse strategy floats wastewater testing, AI, more treatment and faith-based options

Psychological Medicine: Risk factors for the development of opioid use disorder after first opioid prescription: a Swedish national study

--- 

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. 

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/